稳健医疗 (300888.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(稳健医疗)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 2,036,537,874.742,124,487,823.261,909,017,281.072,174,579,540.201,743,604,478.341,914,723,348.102,352,114,690.56
 营业收入(元) 2,036,537,874.742,124,487,823.261,909,017,281.072,174,579,540.201,743,604,478.341,914,723,348.102,352,114,690.56
二、营业总成本(元) 1,853,679,454.191,868,801,015.391,707,213,229.422,172,687,257.611,612,000,732.661,615,364,006.291,885,291,798.07
 营业成本(元) 1,079,450,642.131,068,596,307.14999,874,135.441,179,641,898.48923,527,182.54918,085,598.951,153,342,607.77
 研发费用(元) 88,538,374.4467,143,092.5775,999,859.7653,155,188.0174,260,478.2883,457,212.65111,178,989.49
 营业税金及附加(元) 15,218,687.5320,342,958.3616,313,320.7616,402,757.4412,664,504.8218,087,522.4919,258,686.12
 销售费用(元) 520,143,174.10577,903,431.33477,837,652.89644,985,943.04485,063,651.62490,123,299.97470,319,611.47
 管理费用(元) 158,291,863.23157,656,889.23151,789,137.17263,263,536.68140,787,382.60140,851,348.30148,745,353.84
 财务费用(元) -7,963,287.24-22,841,663.24-14,600,876.6015,237,933.96-24,302,467.20-35,240,976.07-17,553,450.62
  其中:利息费用(元) 13,643,548.5112,760,083.6611,255,576.0015,046,540.7215,503,507.7217,321,654.7115,569,859.54
  其中:利息收入(元) 32,700,639.5333,427,852.8723,584,993.1425,126,327.1238,924,400.9436,695,411.8233,167,722.84
 资产减值损失(元) -3,302,862.99-38,230,159.81-17,745,343.35-246,329,773.01-46,637,398.49-5,804,283.61-94,990,599.76
 信用减值损失(元) 726,996.97-3,242,444.64-5,053,372.804,523,880.36-2,630,344.67512,182.522,319,791.09
三、其他经营收益
 加:公允价值变动收益(元) -4,835,573.37-6,852,723.7814,430,436.62-12,896,924.00-64,808.7613,506,219.8546,133,616.18
 加:投资收益(元) 20,722,499.9518,759,073.8914,686,022.3051,500,979.0936,429,460.7626,870,229.7612,542,211.37
  其中:对联营企业和合营企业的投资收益(元) -4,002,934.15-7,729,997.8360,784.071,060,085.48-1,059,296.01641,011.13939,807.61
 资产处置收益(元) 830,099.031,133,256.29797,543.99-1,569,640,011.811,596,517,210.72--
 其他收益(元) 13,011,385.2619,928,404.5917,354,528.5131,456,275.3322,968,304.7726,801,916.8919,878,777.62
四、营业利润(元) 210,010,965.40247,182,214.41226,273,866.92-1,739,493,291.451,738,186,170.01366,570,358.32452,706,688.99
 加:营业外收入(元) 832,097.603,890,234.942,253,121.577,840,889.272,075,008.444,866,898.561,835,700.21
 减:营业外支出(元) 1,638,712.471,451,994.544,766,165.4774,243,136.155,592,064.163,528,625.331,378,322.70
五、利润总额(元) 209,204,350.53249,620,454.81223,760,823.02-1,805,895,538.331,734,669,114.29367,908,631.55453,164,066.50
 减:所得税费用(元) 29,239,625.5236,903,349.7530,247,700.49-248,508,798.83254,923,427.2549,662,925.5865,223,533.57
六、净利润(元) 179,964,725.01212,717,105.06193,513,122.53-1,557,386,739.501,479,745,687.04318,245,705.97387,940,532.93
(一)按经营持续性分类
  持续经营净利润(元) 179,964,725.01212,717,105.06193,513,122.53-1,557,386,739.501,479,745,687.04318,245,705.97387,940,532.93
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 168,816,611.93201,725,567.26182,424,811.95-1,567,370,061.311,466,156,270.99304,678,887.35376,938,135.34
  少数股东损益(元) 11,148,113.0810,991,537.8011,088,310.589,983,321.8113,589,416.0513,566,818.6211,002,397.59
 扣除非经常性损益后的净利润(元) 144,916,756.25182,713,299.22144,201,815.60-208,878,117.7870,847,155.84240,223,583.10309,834,876.09
七、每股收益
 一、基本每股收益(元) 0.290.350.31-2.672.490.270.89
 二、稀释每股收益(元) 0.290.350.31-2.672.490.270.89
八、其他综合收益(元) -10,491,014.47-6,410,613.481,028,878.34704,871.79-731,622.253,376,019.66-725,528.08
 归属于母公司股东的其他综合收益(元) -5,966,200.77-3,531,100.35599,560.21263,818.08-395,099.061,981,098.48-417,226.20
 归属于少数股东的其他综合收益(元) -4,524,813.70-2,879,513.13429,318.13441,053.71-336,523.191,394,921.18-308,301.88
九、综合收益总额(元) 169,473,710.54206,306,491.58194,542,000.87-1,556,681,867.711,479,014,064.79321,621,725.63387,215,004.85
 归属于母公司所有者的综合收益总额(元) 162,850,411.16198,194,466.91183,024,372.16-1,567,106,243.231,465,761,171.93306,659,985.83376,520,909.14
 归属于少数股东的综合收益总额(元) 6,623,299.388,112,024.6711,517,628.7110,424,375.5213,252,892.8614,961,739.8010,694,095.71
公告日期 2024-10-292024-08-282024-04-252024-04-252023-10-242023-08-162023-04-25
审计意见(境内) 标准无保留意见

前瞻产业研究院